Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
If we could, doctor, and forgive me for interrupting but this seems to be a good moment to then now connect all the dots to why so many people, even if they go off of it after a while, are trying GLP-1s for things that seem to be far from the original metabolic or diabetes related treatments, right
These drugs mimic glucagon-like peptide 1, a hormone that stimulates insulin production in the body
May improve tolerability of GLP-1-based treatments
This protein is responsible for reabsorbing glucose back into the bloodstream, but SGLT2 inhibitors prevent this from happening, resulting in increased glucose excretion in the urine, which improves glycemic control in people with T2DM
Similarly, In diabetics with progressive kidney failure, treatment significantly reduced progression and the need for dialysis or kidney transplantation
